Extending the role of antithrombotic agents: An example based on the low-molecular-weight heparin, tinzaparinHAINER, James W; SPROGEL, Per; LINDENSTROEM, Ewa et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, pp 3-9, issn 0094-6176, 7 p., SUP1Conference Paper

The effect of taurolidine on experimental thrombus formationKAPTANOGLU, Levent; KUCUK, Hasan Fehmi; COLAK, Elif et al.European journal of pharmacology. 2008, Vol 578, Num 2-3, pp 238-241, issn 0014-2999, 4 p.Article

Differentiating Low-Molecular-Weight Heparins Based on Chemical, Biological, and Pharmacologic Properties : Implications for the Development of Generic Versions of Low-Molecular-Weight HeparinsJESKE, Walter P; WALENGA, Jeanine M; HOPPENSTEADT, Debra A et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, Num 1, pp 74-85, issn 0094-6176, 12 p.Article

Guidelines on the use and monitoring of heparinBAGLIN, T; BARROWCLIFFE, T. W; COHEN, A et al.British journal of haematology. 2006, Vol 133, Num 1, pp 19-34, issn 0007-1048, 16 p.Article

Low-molecular-weight heparin in pediatric patientsSUTOR, Anton Heinz; CHAN, Anthony K. C; MASSICOTTE, Patricia et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, pp 31-39, issn 0094-6176, 9 p., SUP1Conference Paper

Timing of postpartum enoxaparin administration and severe postpartum hemorrhageFREEDMAN, Rachel A; BAUER, Kenneth A; NEUBERG, Donna S et al.Blood coagulation & fibrinolysis. 2008, Vol 19, Num 1, pp 55-59, issn 0957-5235, 5 p.Article

Differential effects of heparin and low molecular weight heparin on osteoblastogenesis and adipogenesis in vitroOSIP, Stephanie L; BUTCHER, Martin; YOUNG, Edward et al.Thrombosis and haemostasis. 2004, Vol 92, Num 4, pp 803-810, issn 0340-6245, 8 p.Article

The potential for circular dichroism as an additional facile and sensitive method of monitoring low-molecular-weight heparins and heparinoidsRUDD, Timothy R; SKIDMORE, Mark A; GUIMOND, Scott E et al.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 874-878, issn 0340-6245, 5 p.Conference Paper

A simple capillary electrophoresis method for the rapid separation and determination of intact low molecular weight and unfractionated heparinsPATEL, Rahul P; NARKOWICZ, Christian; HUTCHINSON, Joseph P et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 46, Num 1, pp 30-35, issn 0731-7085, 6 p.Article

Structural features of low-molecular-weight heparins affecting their affinity to antithrombinBISIO, Antonella; VECCHIETTI, Davide; CITTERIO, Laura et al.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 865-873, issn 0340-6245, 9 p.Conference Paper

Low molecular weight heparin in pregnancy: current issuesGREER, Ian; HUNT, Beverley J.British journal of haematology. 2005, Vol 128, Num 5, pp 593-601, issn 0007-1048, 9 p.Article

Bridging therapy and oral anticoagulation: current and future prospectsSPYROPOULOS, Alex C.Current opinion in hematology. 2010, Vol 17, Num 5, pp 444-449, issn 1065-6251, 6 p.Article

Heparin-induced thrombocytopenia following hip and knee arthroplastyCRAIK, Johnathan D; COBB, Andrew G.British journal of haematology. 2013, Vol 161, Num 2, pp 255-261, issn 0007-1048, 7 p.Article

The anticoagulant capacity of plasmatic unfractionated heparin decreases at 23°CSTIEF, Thomas W.Blood coagulation & fibrinolysis. 2007, Vol 18, Num 2, pp 209-212, issn 0957-5235, 4 p.Article

Standardization of low molecular weight heparins: a collaborative studyBARROWCLIFFE, T. W; CURTIS, A. D; TOMLINSON, T. P et al.Thrombosis and haemostasis. 1985, Vol 54, Num 3, pp 675-679, issn 0340-6245Article

Development of generic low molecular weight heparins: A perspectiveFAREED, Jawed; LEONG, Wendy; HOPPENSTEADT, Debra A et al.Hematology/oncology clinics of North America. 2005, Vol 19, Num 1, pp v-vi, issn 0889-8588, 18 p.Article

Generic low-molecular-weight heparins: Some practical considerationsFAREED, Jawed; LEONG, Wendy L; HOPPENSTEADT, Debra A et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 6, pp 703-713, issn 0094-6176, 11 p.Conference Paper

Heparin to pentasaccharide and beyond: The end is not in sightMESSMORE, Harry L; WEHRMACHER, William H; COYNE, Erwin et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, pp 81-88, issn 0094-6176, 8 p., SUP1Conference Paper

Localization of heparin and low-molecular-weight heparin in the rat kidneyYOUNG, Edward; DOUROS, Vivian; PODOR, Thomas J et al.Thrombosis and haemostasis. 2004, Vol 91, Num 5, pp 927-934, issn 0340-6245, 8 p.Article

Effects of unfractionated heparin and low-molecular-weight heparin on colonic anastomoses in the presence of experimental peritonitisGUNERHAN, Yusuf; KOKSAL, Neset; GUL, Ozden et al.European surgical research. 2006, Vol 38, Num 3, pp 353-357, issn 0014-312X, 5 p.Article

Heparin and low-molecular-weight heparin: The Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyHIRSH, Jack; RASCHKE, Robert.Chest. 2004, Vol 126, Num 3, pp 188S-203S, issn 0012-3692, SUPConference Paper

Biological and clinical features of low-molecular-weight heparin-induced thrombocytopeniaGRUEL, Yves; POUPLARD, Claire; NGUYEN, Philippe et al.British journal of haematology. 2003, Vol 121, Num 5, pp 786-792, issn 0007-1048, 7 p.Article

Heparin and low-molecular-weight heparin therapy for venous thromboembolism: Will unfractionated heparin survive?HULL, Russell D; PINEO, And Graham F.Seminars in thrombosis and hemostasis. 2004, Vol 30, pp 11-23, issn 0094-6176, 13 p., SUP1Conference Paper

Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugsWALENGA, Jeanine M; JESKE, Walter P; PRECHEL, M. Margaret et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, pp 69-80, issn 0094-6176, 12 p., SUP1Conference Paper

Use of antithrombotic agents during pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyBATES, Shannon M; GREER, Ian A; HIRSH, Jack et al.Chest. 2004, Vol 126, Num 3, pp 627S-644S, issn 0012-3692, SUPConference Paper